NEWS
SUBSCRIBER SEARCH (Requires Login)
  NEW DRUGS
  MARKETED DRUGS
  COMPANY
  TARGETS IN ONCOLOGY
  NEWS SUMMARIES
  COMBINATION TRIALS

Latest Updates

June 2010 New Drug Updates and Additions

Designation

Brand Name

Generic Name

AP5346

ProLindac

Actinium-225-HuM195, HuM195-Ac-225

 

 

CRS-207

 

 

AMG706, AMG-706

 

Motesanib diphosphate

[18F]-ML-10

ApoSense

 

 

ATT (Apoptosis Targeted Therapy)

 

OSU-HDAC42, s-HDAC-42, NSC D736012, AR-42

 

 

ZD6474, AZD6474, AZD-6474

Zactima

Vandetanib

AZD6244, ARRY-142886, ARRY-886

 

 

AVL-292

 

 

BP-100-1.01, L-Grb2, Grb-2

 

 

BKT-140

 

 

GVAX leukemia vaccine, GM-K562, GVAX CML

 

 

MDX-010, MDX-CTLA4; BMS-734016

 

Ipilimumab

BMS-582664

 

Brivanib alalinate

MDX-1307, HCG-VAC, CDX-1307

 

 

CDX-1127

 

 

DOX-LTSL

ThermoDox

Doxorubicin

CP-4055

Elacyt

Ara-C, elacytarabine

CP-4200

 

5-Azacitidine (AzaC)

CP-4126, CO-1.01

 

Gemcitabine 5'-elaidic acid ester

CUDC-101

 

 

CS7017, CS-7017

 

 

XL184, XL 184, EXEL-7184, BMS 907351

 

 

 

StemEX

Carlecortemcel-l

Cur-691, GDC-0449, RG3616

HhAntag

 

HuMax-CD38

 

 

ICT-107

 

 

IMMU-103, hLL2, hCD22, AMG 412

LymphoCide

Epratuzumab

IPP-204106, Nucant 6L

 

 

IRX-2

 

Citoplurikin

AV-951, formerly KRN951

 

Tivozanib

AV-299, SCH900105

 

 

L-BLP25, BLP-25 (formerly BP1-7-KLH)

Stimuvax

 

MGN1601

 

 

MOR 202, MOR202

 

 

NSC-649890, L86-8275, HMR-1275, HMR1275

 

Alvocidib, flavopiridol

NPC-1C

 

Ensituximab

LEP-ETU (formerly PNU-93914)

 

Paclitaxel

Liposome Entrapped Docetaxel for Injection (LE-DT)

 

Docetaxel

NPI-2350 and NPI-2358

 

 

NS-187, INNO-406, CNS-9

 

Bafetinib

LBH 589, LBH589, NVP-LBH589, LBH489B, LBH489A

 

Panobinostat

 

Reolysin (formerly Reosyn)

 

OMP-21M18

 

 

OMP-18R5 and others

 

 

ON 01910.Na, ON01910.Na, ON01910

Estybon

 

ON 24160

 

 

ON 013105

 

 

PX-478

 

 

PX-866, PX866

 

 

PF-3446962, PF-3,446,962, PF-03446962

 

 

PF-2341066, PF-2,341,066, PF-02341066, PF1066, PF-1066

 

Crizotinib

 

Aplidin R (Aplidine)

Plitidepsin, dehydrodidemnin B

PTC299

 

 

PTC-210

 

 

SL-052, SL052

 

Hypocrellin B

VEGF Trap, VEGF-Trap, AVE0005, NSC 724770

 

Aflibercept

SAR3419

 

 

SAR650984

 

 

HuM195/rGel

 

 

CAP-232, TT-232, TLN-232

 

 

ANX-510

CoFactor

Fotrexorin

  

Home   |    Freelance Opportunities   |   New Medicine   |   Site Map   |  Order/Inquiry   
SUBSCRIBER SEARCH:   NEW DRUG   |   MARKETED DRUG   |   COMPANY   |   TARGETS IN ONCOLOGY  

NEW MEDICINE, INC.
P.O. BOX 909, LAKE FOREST, CA 92609
PHONE:  1-949-830-0448     FAX:  1-949-830-0887
INFO@NEWMEDINC.COM